Externa forskningsanslag - december 2022

Young Investigator Award (YIA) Children's Tumor Foundation (CTF), US The Young Investigator Award, initiated in 1985, is CTF’s longest running award program, and provides two-year salary support to early career NF researchers, such as senior doctoral students and post-doctoral researchers, to help them get established as independent NF investigators. Since its… Maximum award: USD 199,800 Closing date: 04 Jan 23 Donald J. Cohen Fellowship in Developmental Social Neuroscience Emory University School of Medicine, US The Donald J. Cohen Fellowship in Developmental Social Neuroscience provides recent college graduates with the opportunity to spend two years engaged in state-of-the-art clinical and basic research with children and families affected by autism spectrum disorders (ASD). Cohen Fellows are directly… Maximum award: USD 70,000 Closing date: 07 Jan 23 NHS Scotland Assure Research Service Apply Now for Funding Ad Applications are now open for a £1.55m research and innovation budget, administrated by Edinburgh Napier University, on behalf of NHS Scotland Assure.  The fund is open to researchers from any country who are looking to deliver safe healthcare environments that are free from avoidable risk.  Closing date: 6th January 2023. Click above to find out more Breast Cancer Research Foundation-AACR NextGen Grants for Transformative Cancer Research American Association for Cancer Research (AACR), US The Breast Cancer Research Foundation-AACR NextGen Grants for Transformative Cancer Research represent the AACR’s flagship funding initiative to stimulate highly innovative research from young investigators. This grant mechanism is intended to promote and support creative, paradigm-shifting cancer… Maximum award: USD 450,000 Closing date: 23 Jan 23 The Bosarge Family Foundation-Waun Ki Hong Scholar Award for Regenerative Cancer Medicine American Association for Cancer Research (AACR), US The Bosarge Family Foundation-Waun Ki Hong Scholar Award for Regenerative Cancer Medicine represents a joint effort to encourage and support postdoctoral or clinical research fellows to conduct highly novel and provocative research in the field of regenerative cancer medicine and to establish a… Maximum award: USD 120,000 Closing date: 07 Feb 23 NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) National Cancer Institute (NCI), US This funding opportunity announcement (FOA) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data;… Maximum award: USD 100,000 Closing date: 22 Feb 23 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) National Cancer Institute (NCI), US This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to… Maximum award: Not specified Closing date: 01 Mar 23 Emerging Leader Grant Award Ivy Foundation, US The Ben & Catherine Ivy Foundation Emerging Leader Award provides grant support to early-to-mid-career investigators conducting high-impact, high-reward translational research for glioblastoma. This award is intended to support ambitious pilot projects designed to identify drug strategies… Maximum award: USD 500,000 Closing date: 01 Mar 23 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) National Cancer Institute (NCI), US This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities… Maximum award: Not specified Closing date: 01 Mar 23 Oswald Vander Veken Prize Fonds National de la Recherche Scientifique, BE This recognises an original contribution to the understanding of tumours of the locomotor apparatus, their causes, prevention, diagnosis and treatment. The prize is worth €25,000. Maximum award: €25,000 Closing date: 01 Mar 23 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) National Cancer Institute (NCI), US The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a… Maximum award: USD 300,000 Closing date: 01 Mar 23 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) National Cancer Institute (NCI), US The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications from currently funded NCI P50 specialized centers proposing to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a… Maximum award: USD 150,000 Closing date: 01 Mar 23 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) National Cancer Institute (NCI), US The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications from currently funded NCI R01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a… Maximum award: USD 300,000 Closing date: 01 Mar 23 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) National Cancer Institute (NCI), US The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications from currently funded NCI U2C Resource-Related Multi-Component Projects and Centers proposing to expand upon original research question(s) from specific projects or otherwise accelerate progress for the… Maximum award: USD 300,000 Closing date: 01 Mar 23 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) National Cancer Institute (NCI), US The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications from currently funded NCI U54 Resource-Related Research Projects proposing to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by… Maximum award: USD 300,000 Closing date: 01 Mar 23 Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional) National Institutes of Health (NIH), US The National Institutes of Health (NIH) participating Institutes and Centers (ICs), in collaboration with the Global Alliance for Chronic Diseases (GACD), invite applications for implementation research focused on addressing risk factors for common noncommunicable diseases (NCDs) in World… Maximum award: Not specified Closing date: 09 Mar 23 Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R61/R33 Clinical Trial Required) National Institutes of Health (NIH), US The National Institutes of Health (NIH) participating Institutes and Centers (ICs), in collaboration with the Global Alliance for Chronic Diseases (GACD), invite applications for implementation research focused on addressing risk factors for common noncommunicable diseases (NCDs) in World… Maximum award: Not specified Closing date: 09 Mar 23 HORIZON-MISS-2023-CANCER-01 - research and innovation actions supporting the implementation of the Mission on Cancer Horizon Europe: Missions, EU This supports proposals that set out a credible pathway to improving cancer control. The budget is €110.7 million. Grants are worth up to €12m each. Maximum award: €12,000,000 Closing date: 12 Apr 23 Other pathogens with epidemic potential call ISIDORE, EU This supports scientists with an interest in epidemic-prone pathogens, including pathogen X. Maximum award: Not specified Closing date: No deadline Respiratory pathogens call ISIDORE, EU This supports scientists with an interest in respiratory pathogens. Maximum award: Not specified Closing date: No deadline Vector-borne pathogens and their vectors call ISIDORE, EU This supports scientists with an interest in the causative agents and vectors of fast-spreading diseases. Maximum award: Not specified Closing date: No deadline